FTC’s Ban of Noncompete Agreements Halted
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
Essential
Subscribe today for access to
Articles and Reports
Six Sigma Can Help Monitor New CLIA Proficiency Testing Changes
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Two Prominent Senators Push CMS to Make Changes on PAMA Rules
...
Already a member? Log in here
AltheaDX Raises $30 Million, Announces New Tests
...
Already a member? Log in here
Pathway Genomics Settles False Claims Case
...
Already a member? Log in here
Palmetto Issues New Codes For BRCA, “Hotspot” Testing
...
Already a member? Log in here
Congressional Members Lobby CMS on PAMA Regulations
...
Already a member? Log in here
HHS’ Top Ten Management Problems Include Labs
...
Already a member? Log in here
ACMG Issues Position Statement on Direct-to- Consumer Tests
...
Already a member? Log in here
Congress Lobbies CMS on PAMA Regulations
...
Already a member? Log in here
FDA Looks Back at Successes and Details Plans for 2016, Including LDTs
...
Already a member? Log in here
Pathway Genomics Denies Wrongdoing, Settles False Claims Allegations for $4 Million
From - G2 Compliance Advisor
As the year came to a close, the Federal Bureau of Investigation and the U.S. Attorney's Office announced December 30, 2015, a $4 million settlement with Pathway Genomics. The San Diego-based laboratory denied wrongdoing but agreed to pay that sum to resolve…